Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Plos Computational Biology|August 24, 2019
Optimizing antibody affinity and stability by the automated design of the variable light-heavy chain interfacesShira Warszawski, Aliza Borenstein Katz, Rosalie Lipsh, et al.
Plos Computational Biology|October 21, 2020
Correction: Optimizing antibody affinity and stability by the automated design of the variable light-heavy chain interfacesShira Warszawski, Aliza Borenstein Katz, Rosalie Lipsh, et al.
Plos One|September 25, 2018
Expression of a recombinant, 4'-Phosphopantetheinylated, active M. tuberculosis fatty acid synthase I in E. coliSzilvia Baron, Yoav Peleg, Jacob Grunwald, et al.
The Journal of Experimental Medicine|May 29, 2013
Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodiesRon Diskin, Florian Klein, Joshua A Horwitz, et al.
Iscience|October 3, 2022
Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concernHadas Cohen-Dvashi, Jonathan Weinstein, Michael Katz, et al.
Nature Medicine|October 9, 2019
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOVStefanie A Ehrhardt, Matthias Zehner, Verena Krähling, et al.
Science (New York, N.Y.)|July 19, 2011
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 bindingJohannes F Scheid, Hugo Mouquet, Beatrix Ueberheide, et al.
The Journal of Experimental Medicine|August 27, 2014
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaquesMasashi Shingai, Olivia K Donau, Ronald J Plishka, et al.
Pageof 6